Parkinson's disease Clinical Trials
Recruiting parkinson's disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat parkinson's disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting parkinson's disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting parkinson's disease trials
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
Low Intensity Focused Ultrasound for Parkinson's Disease
A Behavioral Digital Intervention For Parkinson's Disease
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
Smartshoes for Freezing of Gait in Parkinson's Disease
Study of Transanal Irrigation vs Standard Care for Constipation, Gut Microbiota, and Motor Disorders in Parkinson's Disease
Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)
Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.
Gamification and Physical Activity in PD
Terazosin And Metabolic Engagement in Parkinson's Disease
Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study
Fecal Microbiota Transplantation in Parkinson's Disease.
Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients
Superior Parietal iTBS for PD-MCI
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
Characterization of the Involvement of the Subthalamic Nucleus During Wakefulness and Sleep in Parkinson's Disease: Contribution of Deep Brain Stimulation
NAD Supplementation in Parkinson's Disease
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Temporal Interference Noninvasive Deep Brain Stimulation for Idiopathic Parkinson's Disease and Parkinsonian Syndromes: Effects and Target Exploration
Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease
HF-rTMS Primed Balance Training on Corticomotor Excitability, Balance, and Gait in Parkinson's
The Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Depression in PD
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
Motor and Cognitive Telerehabilitation in a Virtual Environment in Patients With Post-stroke Sequelae and Parkinson's Disease
Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients
Evaluation of a Soft Elbow Exoskeleton and a Haptic Armband in Post-stroke and Parkinson's Disease Patients
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Telerehabilitation Versus Face-to-Face LSVT BIG in Individuals With Parkinson Disease
Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD
Upper Extremity Skills, Trunk Control, and Body Awareness in Parkinson's Disease
Deep Brain Stimulation in Parkinson's Disease: Motor and Functional Outcomes
Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease
Accelerated TMS for Apathy in PD
At-home taVNS for Neurorehabilitation in Parkinson's Disease
RESvEraTrol in Parkinson's Disease (RESET)
Depression, Anxiety and Sleep in Parkinson's Disease
Impact of Diet on the Microbiome-Immune-Brain Axis in Parkinson's Disease
Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology
A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With Motor Fluctuations
Effectiveness of Virtual Reality in Parkinson's Disease: Effects on Balance, Fall Risk, and Exercise Capacity.
Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product.
"Turkish Validity and Reliability of the Heat Sensitivity Scale for Individuals With Parkinson's Disease"
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
The Effect of Eye Exercises in Parkinson's Disease
A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training
Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome
Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"
Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis
Parkinson's disease clinical trials — common questions
Are parkinson's disease clinical trials free to join?
Yes. Participating in a parkinson's disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a parkinson's disease clinical trial?
Each parkinson's disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a parkinson's disease trial near me?
Use the location controls above. We'll show recruiting parkinson's disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many parkinson's disease trials are recruiting right now?
We're currently tracking roughly 221 recruiting parkinson's disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.